Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Survival following treatment of a cardiac malignant fibrous histiocytoma. Chest 2000 Jul;118(1):271-3

Date

07/14/2000

Pubmed ID

10893397

DOI

10.1378/chest.118.1.271

Scopus ID

2-s2.0-0033931224 (requires institutional sign-in at Scopus site)   19 Citations

Abstract

The authors report the successful surgical and chemotherapeutic management of a malignant fibrous histiocytoma with localization in the heart. This rare malignancy has specific morphologic characteristics and is diagnosed in adults when it is already locally aggressive or metastasized. The average survival time for patients with malignant fibrous histiocytoma is < 12 months. Neither clinical nor instrumental signs of recurrence have been detected in this patient after an aggressive surgical resection and a specific therapeutic approach.

Author List

Schena S, Caniglia A, Agnino A, Caruso G, Ferlan G

Author

Stefano Schena MD, PhD Associate Professor in the Surgery department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Aged
Chemotherapy, Adjuvant
Female
Heart Neoplasms
Histiocytoma, Benign Fibrous
Humans